- Home
- ABEO vs EIC Comparison
ABEO vs EIC Comparison
Compare ABEO & EIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ABEO | EIC |
|---|---|---|
| Founded | 1974 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 281.0M | 299.6M |
| IPO Year | 1980 | 2019 |
Fundamental Metrics
Financial Performance| Metric | ABEO | EIC |
|---|---|---|
| Price | $5.06 | $10.98 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $18.20 | $14.00 |
| AVG Volume (30 Days) | ★ 1.6M | 277.8K |
| Earning Date | 11-12-2025 | 11-13-2025 |
| Dividend Yield | N/A | ★ 14.26% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.29 | 1.14 |
| Revenue | $400,000.00 | ★ $59,262,402.00 |
| Revenue This Year | N/A | $37.84 |
| Revenue Next Year | $1,590.36 | $23.33 |
| P/E Ratio | ★ $4.17 | $9.62 |
| Revenue Growth | N/A | ★ 44.30 |
| 52 Week Low | $3.93 | $10.81 |
| 52 Week High | $7.54 | $16.39 |
Technical Indicators
Market Signals| Indicator | ABEO | EIC |
|---|---|---|
| Relative Strength Index (RSI) | 52.04 | 25.69 |
| Support Level | $4.53 | $10.82 |
| Resistance Level | $5.61 | $11.44 |
| Average True Range (ATR) | 0.27 | 0.22 |
| MACD | 0.08 | -0.00 |
| Stochastic Oscillator | 49.30 | 16.32 |
Price Performance
Historical ComparisonAbout ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
About EIC Eagle Point Income Company Inc.
Eagle Point Income Co Inc is a closed-end management investment company. Its primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation. The Company seeks to achieve its investment objectives by investing in junior debt tranches of collateralized loan obligations, or "CLOs," that are collateralized by a portfolio consisting of below-investment grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.